RE:Below conscensus again Wow, it looks like you are surprised.........!
Nothing new, the same over and over and over again!
TH, once so promising, is toast, management earned a lot of money and shareholders lost allmost all.
It will continu that way till the final curtain fall.................
![](https://assets.stockhouse.com/kentico-cms/0324-00/images/Sprite.svg#id-Avatar_Default)
Trogarzon - (9/26/2023 8:02:55 AM)
Below conscensus again
How can they say strong prescription growth of Egrifta SV to later say higher sales mainly the result of price increases in the same PR. The ongoing concern is explained in such a way that it is difficult the understant what it meens. No mention of Nash at all, nothing about Th1902 enrolment numbers. Hey it's better than bankrupcy last month and looking ahead once again but why would you buy this stock now. It looks like everything they make in next years will be allocated to dept reimbursement and after that we'll be left with little patent life in our pipeline if nothing else pan's out or if a free new product does'nt fall of the sky.